Search Results - "CRIJNS, H. J. M. G"

Atrial tissue Doppler imaging for prediction of new-onset atrial fibrillation by De Vos, C B, Weijs, B, Crijns, H J G M, Cheriex, E C, Palmans, A, Habets, J, Prins, M H, Pisters, R, Nieuwlaat, R, Tieleman, R G

“…The total atrial conduction time (TACT) is an independent predictor of atrial fibrillation (AF). A new transthoracic echocardiographic tool to determine TACT…”
Get more information

Determining the optimal interval for imaging surveillance of ascending aortic aneurysms by Adriaans, B. P., Ramaekers, M. J. F. G., Heuts, S., Crijns, H. J. G. M., Bekkers, S. C. A. M., Westenberg, J. J. M., Lamb, H. J., Wildberger, J. E., Schalla, S.

“…Background Cardiovascular guidelines recommend (bi-)annual computed tomography (CT) or magnetic resonance imaging (MRI) for surveillance of the diameter of…”
Get full text

Mitral prolapsing volume is associated with increased cardiac dimensions in patients with mitral annular disjunction by Luyten, P., Heuts, S., Cheriex, E., Olsthoorn, J. R., Crijns, H. J. G. M., Winkens, B., Roos-Hesselink, J. W., Sardari Nia, P., Schalla, S.

“…Introduction In patients with mitral annular disjunction (MAD), it can be difficult to assess the severity of mitral regurgitation (MR), as they present with…”
Get full text

Paradigm shifts in pathophysiology and management of atrial fibrillation—a tale of the RACE trials in the Netherlands by Crijns, H. J. G. M., Van Gelder, I. C.

“…In the past 20 years the Netherlands-based RACE trials have investigated important concepts in clinical atrial fibrillation (AF). Their scope ranged from…”
Get full text

Optimal long-term antithrombotic management of atrial fibrillation: life cycle management by Pisters, R., Elvan, A., Crijns, H. J. G. M., Hemels, M. E. W.

“…Optimal antithrombotic management of atrial fibrillation equals balancing between prevention of arterial thromboembolism, predominantly ischaemic stroke, and…”
Get full text

Catheter ablation in highly symptomatic Brugada patients: a Dutch case series by Haanschoten, D. M., Elvan, A., Postema, P. G., Smit, J. J. J., Adiyaman, A., ter Bekke, R. M. A., Asaad, N., Aanhaanen, W. T. J., Misier, A. R. Ramdat, Delnoy, P. P. H. M., Crijns, H. J. G. M., Wilde, A. A. M.

“…Aims In the past few years, promising results were described in targeting the arrhythmogenic substrate of the epicardial right ventricular outflow tract (RVOT)…”
Get full text

Real-life use of Rivaroxaban in the Netherlands: data from the Xarelto for Prevention of Stroke in Patients with Atrial Fibrillation (XANTUS) registry by Pisters, R., van Vugt, S. P. G., Brouwer, M. A., Elvan, A., ten Holt, W. L., Zwart, P. A. G., Kirchhof, P., Crijns, H. J. G. M., Hemels, M. E. W.

“…Background The Xarelto for Prevention of Stroke in Patients with Atrial Fibrillation (XANTUS) registry investigated the safety and efficacy of the factor Xa…”
Get full text

Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity by Hillege, H. L., Janssen, W. M. T., Bak, A. A. A., Diercks, G. F. H., Grobbee, D. E., Crijns, H. J. G. M., Van Gilst, W. H., De Zeeuw, D., De Jong, P. E.

“… Hillege HL, Janssen WMT, Bak AAA, Diercks GFH, Grobbee DE, Crijns HJGM, van Gilst WH, de Zeeuw D, de Jong PE for the PREVEND Study group (University of…”
Get full text

Clinical determinants of early spontaneous conversion to sinus rhythm in patients with atrial fibrillation by Pluymaekers, N. A. H. A., Dudink, E. A. M. P., Weijs, B., Vernooy, K., Hartgerink, D. E. J., Jacobs, J. S., Erküner, Ö., Marcks, N. G. H. M., van Cauteren, Y. J. M., Dinh, T., ter Bekke, R. M. A., Sels, J. E. M. W., Delnoij, T. S. R., Geyik, Z., Driessen, R. G. H., Linz, D. K., den Uijl, D. W., Crijns, H. J. G. M., Luermans, J. G. L. M.

“…Background The current standard of care for acute atrial fibrillation (AF) focuses primarily on immediate restoration of sinus rhythm by cardioversion,…”
Get full text

Idiopathic atrial fibrillation patients rapidly outgrow their low thromboembolic risk: a 10-year follow-up study by Weijs, B., Dudink, E. A. M. P., de Vos, C. B., Limantoro, I., Tieleman, R. G., Pisters, R., Cheriex, E. C., Luermans, J. G. L. M., Crijns, H. J. G. M.

“…Background Healthy atrial fibrillation (AF) patients will eventually outgrow their low thromboembolic risk. The purpose of this study is to compare the…”
Get full text

Contemporary management of patients with atrial fibrillation in the Netherlands and Belgium: a report from the EORP-AF long-term general registry by Erküner, Ö., van Eck, M., Xhaet, O., Verheij, H., Neefs, J., Duygun, A., Nijmeijer, R., Saïd, S. A. M., Uiterwaal, H., Hagens, V., Bhagwandien, R., Szili-Torok, T., Bijsterveld, N., Tjeerdsma, G., Vijgen, J., Friart, A., Hoffer, E., Evrard, P., Srynger, M., Meeder, J., de Groot, J. R., van Opstal, J., Gevers, R., Lip, G. Y. H., Boriani, G., Crijns, H. J. G. M., Luermans, J. G. L. M., Mairesse, G. H.

“…Background Contemporary data regarding the characteristics, treatment and outcomes of patients with atrial fibrillation (AF) are needed. We aimed to assess…”
Get full text

Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and the Netherlands: insights from the ETNA-AF-Europe study by de Vries, T. A. C., Hemels, M. E. W., Cools, F., Crijns, H. J. G. M., Yperzeele, L., Vanacker, P., Blankoff, I., Lancellotti, P., Mairesse, G. H., de Veer, A., Casado Arroyo, R., Catez, E., de Pauw, M., Vanassche, T., de Asmundis, C., Kirchhof, P., De Caterina, R., de Groot, J. R.

“…Background Studies on the use of non-vitamin K antagonist oral anticoagulants in unselected patients with atrial fibrillation (AF) show that clinical…”
Get full text

Stroke risk in patients with device-detected atrial high-rate episodes by Erküner, Ö., Rienstra, M., Van Gelder, I. C., Schotten, U., Crijns, H. J. G. M., Luermans, J. G. L. M.

“…Cardiovascular implantable electronic devices (CIEDs) can detect atrial arrhythmias, i. e. atrial high-rate episodes (AHRE). The thrombo-embolic risk in…”
Get full text

The presence of an atrial electromechanical delay in idiopathic atrial fibrillation as determined by tissue Doppler imaging by Weijs, B, de Vos, C.B, Limantoro, I, Cheriex, E.C, Tieleman, R.G, Crijns, H.J.G.M

Get full text

Treatment of atrial fibrillation by Blaauw, Y, Crijns, H J G M

Get more information

Atrial fibrillation: insights from clinical trials and novel treatment options by Blaauw, Y., Crijns, H. J. G. M.

“…  Blaauw Y, Crijns HJGM (University Hospital Maastricht, Maastricht, The Netherlands). Atrial fibrillation: insights from clinical trials and novel treatment…”
Get full text

Presence and extent of cardiac computed tomography angiography defined coronary artery disease in patients presenting with syncope by Altintas, S., Dinh, T., Marcks, N. G. H. M., Kok, M., Aerts, A. J. J., Weijs, B., Blaauw, Y., Wildberger, J. E., Das, M., Kietselaer, B. L. J. H., Crijns, H. J. G. M.

“…Background In syncope patients, presence of coronary artery disease (CAD) is associated with poor prognosis. However, data concerning CAD prevalence in syncope…”
Get full text

No effect of rosuvastatin on left ventricular hypertrophy in patients with hypertension: A prospective randomised open-label study with blinded endpoint assessment by FOLKERINGA, R. J, DE VOS, C, PINTO, Y. M, HABETS, J, DE LEEUW, P. W, TIELEMAN, R. G, PRINS, M. H, VAN DIEIJEN-VISSER, M, CRIJNS, H. J. G. M

“…This study tested the hypothesis that statins may reduce left ventricular hypertrophy (LVH) in patients with hypertension and LVH. A prospective randomised…”
Get full text

Accrochage and the flirting rhythms by Dennert, R, Alzand, B.S.N, Crijns, H.J.G.M

“…Abstract This case demonstrates the intermittent appearance of two different rhythms with one influencing the behaviour of the other and neither is dominant…”
Get full text

Antithrombotic drug prescription in atrial fibrillation and its rationale among general practitioners, internists and cardiologists in The Netherlands--The EXAMINE-AF study. A questionnaire survey by Dinh, T, Nieuwlaat, R, Tieleman, R G, Büller, H R, van Charante, N A Mensing, Prins, M H, Crijns, H J G M

“…The objective of the EXAMINE-AF study was to record and compare antithrombotic treatment in patients with atrial fibrillation (AF) in daily clinical practice…”
Get more information